Pfizer wins on adequate warning in Prempro breast cancer suit

Bloomberg News reports: Pfizer Inc.’s Prempro, a hormone once used by millions of women to ease menopause symptoms, almost doubled the death risk from breast cancer, a U.S. study found. The findings from the U.S.-funded Women’s Health Initiative are the first to tie Pfizer’s hormone replacement therapy Prempro, already linked to higher breast cancer and… Continue reading Pfizer wins on adequate warning in Prempro breast cancer suit